Ouro Fino is a quiet Brazilian specialist: it makes medicines and vaccines for cattle, pigs, horses, and pets, and it has turned a niche into a profitable business. Full nameOuro Fino Saúde Animal Participações S.A. Tickers / exchangeOFSA3 / B3 (São Paulo) HeadquartersCravinhos, São Paulo, Brazil SectorHealthcare — animal health Employees1,086 Market valueR$1.40 billion (US$273 million) Yearly salesR$1.37 billion (US$266 million) Net profitR$222.3 million (US$43.4 million) Net margin17.3% Return on equity31.8% Price-to-earnings5.9 Dividend yield5.0% Websiteourofinosaudeanimal.com What it is Ouro Fino develops, makes, and sells veterinary medicines and vaccines. Its main …
Company Intelligence — Institutional Access
This dossier is part of our Company Intelligence database.
Full profiles, exchange dossiers and the regional intelligence briefs are available to institutional subscribers. Professional from US$490/year, Corporate US$1,450, Institutional US$3,900.
See institutional access →Already a subscriber? Log in.
Part of LatAm Company Intelligence
This company profile belongs to The Rio Times' research on every listed company and exchange in Latin America and the Caribbean. Browse the full intelligence hub →
Not ready to buy? Try Company Intelligence free for 14 days →
Editorial responsibility: Matthias Camenzind, Editor-in-Chief · Editorial standards · Report an error
Read More from The Rio Times
The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map →